Slc25a21tm1d(KOMP)Wtsi
Targeted Allele Detail
|
|
| Symbol: |
Slc25a21tm1d(KOMP)Wtsi |
| Name: |
solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21; targeted mutation 1d, Wellcome Trust Sanger Institute |
| MGI ID: |
MGI:5629856 |
| Gene: |
Slc25a21 Location: Chr12:56759419-57244257 bp, - strand Genetic Position: Chr12, 24.54 cM
|
| Alliance: |
Slc25a21tm1d(KOMP)Wtsi page
|
| IMPC: |
Slc25a21 gene page |
|
| Mutant Cell Line: |
EPD0085_1_D04 |
| Germline Transmission: |
Earliest citation of germline transmission:
J:215078
|
| Parent Cell Line: |
JM8.F6 (ES Cell)
|
| Strain of Origin: |
C57BL/6N
|
| Project Collection: |
KOMP-CSD
|
|
| Allele Type: |
|
Targeted (Null/knockout) |
| Mutations: |
|
Insertion, Intragenic deletion
Vector: L1L2_Bact_P
|
| |
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 56821858 of Chromosome 12 upstream of the critical exon 4 (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site is inserted downstream of the targeted exon 4 at position 56822635. The critical exon 4 is thus flanked by loxP sites. Flp recombinase expression removed the selection cassette. Subsequent cre expression resulted in a knockout mouse. Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml.
(J:215078)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
|
|
| Original: |
J:215078 Maguire S, et al., Targeting of Slc25a21 is associated with orofacial defects and otitis media due to disrupted expression of a neighbouring gene. PLoS One. 2014;9(3):e91807 |
| All: |
4 reference(s) |
|